Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Mrazek

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Addiction Biology|December 17, 2009
Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremensVictor M Karpyak, Joanna M Biernacka, Mark W Vander Weg, et al.
Pharmacogenetics and Genomics|September 11, 2009
CYP2D6: novel genomic structures and allelesWhitney E Kramer, Denise L Walker, Dennis J O'Kane, et al.
Neuropharmacology|May 23, 2012
Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1David J Hinton, Moonnoh R Lee, Taylor L Jacobson, et al.
Archives of Pediatrics & Adolescent Medicine|March 7, 2002
How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, MinnWilliam J Barbaresi, Slavica K Katusic, Robert C Colligan, et al.
The American Journal on Addictions|December 24, 2010
Utilization of residential alcoholism treatment in bipolar disorderDaniel K Hall-Flavin, Terry D Schneekloth, Larissa L Loukianova, et al.
The American Journal on Addictions|July 27, 2010
Gender differences in the relationship between depressive symptoms and cravings in alcoholismNelli Boykoff, Terry D Schneekloth, Daniel Hall-Flavin, et al.
Therapeutic Drug Monitoring|November 25, 2010
Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxineDonald E McAlpine, Joanna M Biernacka, David A Mrazek, et al.
International Psychogeriatrics|June 12, 2004
De novo genesis of neuropsychiatric symptoms in mild cognitive impairment (MCI)Yonas E Geda, Glenn E Smith, David S Knopman, et al.
The American Journal on Addictions|August 20, 2013
A retrospective study of gender differences in depressive symptoms and risk of relapse in patients with alcohol dependenceOsama A Abulseoud, Victor M Karpyak, Terry Schneekloth, et al.
Pharmacogenetics and Genomics|September 11, 2013
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient settingDaniel K Hall-Flavin, Joel G Winner, Josiah D Allen, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Addiction Biology|December 17, 2009
Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremensVictor M Karpyak, Joanna M Biernacka, Mark W Vander Weg, et al.
Pharmacogenetics and Genomics|September 11, 2009
CYP2D6: novel genomic structures and allelesWhitney E Kramer, Denise L Walker, Dennis J O'Kane, et al.
Neuropharmacology|May 23, 2012
Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1David J Hinton, Moonnoh R Lee, Taylor L Jacobson, et al.
Archives of Pediatrics & Adolescent Medicine|March 7, 2002
How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, MinnWilliam J Barbaresi, Slavica K Katusic, Robert C Colligan, et al.
The American Journal on Addictions|December 24, 2010
Utilization of residential alcoholism treatment in bipolar disorderDaniel K Hall-Flavin, Terry D Schneekloth, Larissa L Loukianova, et al.
The American Journal on Addictions|July 27, 2010
Gender differences in the relationship between depressive symptoms and cravings in alcoholismNelli Boykoff, Terry D Schneekloth, Daniel Hall-Flavin, et al.
Therapeutic Drug Monitoring|November 25, 2010
Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxineDonald E McAlpine, Joanna M Biernacka, David A Mrazek, et al.
International Psychogeriatrics|June 12, 2004
De novo genesis of neuropsychiatric symptoms in mild cognitive impairment (MCI)Yonas E Geda, Glenn E Smith, David S Knopman, et al.
The American Journal on Addictions|August 20, 2013
A retrospective study of gender differences in depressive symptoms and risk of relapse in patients with alcohol dependenceOsama A Abulseoud, Victor M Karpyak, Terry Schneekloth, et al.
Pharmacogenetics and Genomics|September 11, 2013
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient settingDaniel K Hall-Flavin, Joel G Winner, Josiah D Allen, et al.
Pageof 6